(Q44360422)

English

Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer

scientific article published in March 2003

Statements

Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer (English)
Christine E Swenson
Lois E Bolcsak
Gerald Batist
Troy H Guthrie
Katherine H Tkaczuk
Harold Boxenbaum
Lauri Welles
Shein-Chung Chow
Rupinder Bhamra
Philip Chaikin
1 March 2003
239-246

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit